ABSTRACT Inequity in health research is understood as a major impediment to development.The paper uses empirical analysis performed on a unique data set of publications and clinical trials related to cancer research to explore the public policy dimensions of health care research in India. It traces disparities that result from predilections in science technology and innovation policies in India. The paper analyses disparity in health research using emerging technologies and its implications for equity in health research. The paper argues that the use of emerging technologies in cancer research has shifted research focus from cancers affecting poor population in India. Abbreviations AA – Age Adjusted Incidence Rates; CTRI – Clinical Trail Registry of India; DBT – Department of Biotechnology; DST – Department of Science and Technology; ICMR – Indian Council for Medical Research; Mabs – Monoclonal antibodies; NBDS – National Biotechnology Development Strategy; NCI – National Cancer Institute; NSTI – Nanoscience and Technology Initiative; SCI – Science Citation Index; TB – Tuberculosis; WOS – Web of Science.

中文翻译：

---

印度的新兴技术和创新政策：癌症研究中的差异如何加剧健康不平等？

摘要卫生研究中的不平等被理解为发展的主要障碍。本文使用对与癌症研究相关的出版物和临床试验的独特数据集进行的实证分析，以探索印度卫生保健研究的公共政策层面。它追溯了印度科学技术和创新政策偏好所导致的差距。本文分析了使用新兴技术进行的健康研究中的差异及其对健康研究公平性的影响。该论文认为，在癌症研究中使用新兴技术已经将研究重点从影响印度贫困人口的癌症转移了出去。缩写AA –年龄调整后的发病率；CTRI –印度临床试验注册处；DBT –生物技术系；DST –科学技术部；ICMR –印度医学研究理事会；单克隆抗体–单克隆抗体；NBDS –国家生物技术发展战略；NCI –国家癌症研究所；NSTI –纳米科学与技术计划；SCI –科学引文索引；结核病–结核；WOS –科学网。